Globus Enterprise Value Multiple from 2010 to 2025

GMED Stock  USD 90.80  0.33  0.36%   
Globus Medical's Enterprise Value Multiple is increasing over the years with slightly volatile fluctuation. Enterprise Value Multiple is expected to dwindle to 13.51. During the period from 2010 to 2025 Globus Medical Enterprise Value Multiple annual values regression line had geometric mean of  14.90 and mean square error of  42.64. View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
15.79
Current Value
13.51
Quarterly Volatility
7.86949143
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Globus Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Globus Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 174.8 M, Interest Expense of 24.3 M or Total Revenue of 1.9 B, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 1.65. Globus financial statements analysis is a perfect complement when working with Globus Medical Valuation or Volatility modules.
  
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Latest Globus Medical's Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Globus Medical over the last few years. It is Globus Medical's Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Globus Medical's overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Slightly volatile
   Enterprise Value Multiple   
       Timeline  

Globus Enterprise Value Multiple Regression Statistics

Arithmetic Mean16.61
Geometric Mean14.90
Coefficient Of Variation47.37
Mean Deviation6.09
Median15.79
Standard Deviation7.87
Sample Variance61.93
Range29.2542
R-Value0.60
Mean Square Error42.64
R-Squared0.36
Significance0.01
Slope0.99
Total Sum of Squares928.93

Globus Enterprise Value Multiple History

2025 13.51
2024 15.79
2023 17.54
2022 24.03
2021 28.31
2020 34.73
2019 23.26

About Globus Medical Financial Statements

Globus Medical stakeholders use historical fundamental indicators, such as Globus Medical's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Although Globus Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Globus Medical's assets and liabilities are reflected in the revenues and expenses on Globus Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Globus Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Enterprise Value Multiple 15.79  13.51 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Globus Medical is a strong investment it is important to analyze Globus Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Globus Medical's future performance. For an informed investment choice regarding Globus Stock, refer to the following important reports:
Check out the analysis of Globus Medical Correlation against competitors.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Globus Medical. If investors know Globus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Globus Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
42.231
Earnings Share
0.63
Revenue Per Share
18.217
Quarterly Revenue Growth
0.631
Return On Assets
0.0473
The market value of Globus Medical is measured differently than its book value, which is the value of Globus that is recorded on the company's balance sheet. Investors also form their own opinion of Globus Medical's value that differs from its market value or its book value, called intrinsic value, which is Globus Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Globus Medical's market value can be influenced by many factors that don't directly affect Globus Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Globus Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Globus Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Globus Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.